Company: DMAAR
Filing Date: 2025-11-18
Form Type: 10-Q
Source: 0001213900-25-112096
Chunk: 137

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-11-18
Form: 10-Q
Item: Part I, Item 3
Chunk 137
---
 Document
  
    104 
    Cover Page Interactive
    Data File (formatted as Inline XBRL and contained in Exhibit 101)

    *
    Furnished
    herewith

25

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.

    Date:
    November 18, 2025
    DRUGS
    MADE IN AMERICA ACQUISITION CORP.

    By:
    /s/
    Lynn Stockwell

    Name: 
    Lynn
    Stockwell

    Title:
    Chief
    Executive Officer

    (Principal
    Executive Officer)

    By:
    /s/
    Saleem Elmasri

    Name:
    Saleem
    Elmasri

    Title:
    Chief
    Financial Officer

    (Principal
    Financial and Accounting Officer)

26

http://fasb.org/srt/2025#ChiefExecutiveOfficerMember
0002028614
false
Q3
--12-31

    0002028614

    2025-01-01
    2025-09-30

    0002028614
    
      dmaau:UnitsMember

    2025-01-01
    2025-09-30

    0002028614
    
      us-gaap:CommonStockMember

    2025-01-01
    2025-09-30

    0002028614
    
      dmaau:RightMember

    2025-01-01
    2025-09-30

    0002028614

    2025-11-18

    0002028614

    2025-09-30

    0002028614

    2024-12-31

    0002028614
    
      us-gaap:RelatedPartyMember

    2025-09-30

    0002028614
    
      us-gaap:RelatedPartyMember

    2024-12-31

    0002028614

    2025-07-01
    2025-09-30

    0002028614

    2024-07-01
    2024-09-30

    000202